Original ArticleAssociation of interleukin-1β –511 C/T polymorphism with tobacco-associated cancer in northeast India: a study on oral and gastric cancer
Section snippets
Materials and methods
The present case-control study was performed on 126 histopathologically diagnosed GC cases, 125 OC cases, and a total of 207 age- and sex-matched controls collected during the period of December 2005 to December 2010. Only cases with the stomach or oral cavity as their primary site of cancer were included in the study. All study participants provided informed consent for participation in this research, which was conducted under a protocol approved by the institutional ethics committee of the
Study population description
The demographic distribution of the studied population is summarized in Table 1. A higher percentage of males than females was seen in both cancer groups. The age (mean ± SD) of cases and controls were, respectively, 56.54 ± 13.5 years and 52.34 ± 13.5 years for GC and 54.11 ± 12.27 years and 52.34 ± 13.5 years for OC, with significant risk after 50 years of age (Table 1). Deviation from Hardy–Weinberg equilibrium (HWE) was seen in this population for OC and controls respectively (χ2 = 10.94; P
Discussion
The pivotal roles of cytokines in regulating tumor progression make them attractive candidates for genetic host markers in evaluating individual susceptibility to the development of different cancers. Cumulative evidence suggests that IL-1β plays an important role in tumorigenesis and development of cancer (11). Studies have shown an association of the IL-1β −511 CC genotype with lung cancer 28, 29 and hepatocellular carcinoma (30), whereas the TT genotype is associated with breast cancer (19),
Acknowledgments
The study was funded by a grant from the Indian Council of Medical Research, New Delhi (Ref. No. 49/3 RMRC/NE/2005-NCD-II) One of the authors (Meena Lakhanpal) thanks the University Grants Commission, India, (Ref. No: 20-1212009 (ai)EU-lV) for providing research fellowship.
References (51)
Biologic basis for interleukin-1 in disease
Blood
(1996)- et al.
Effects of micro-environment- and malignant cell-derived interleukin-1 in carcinogenesis, tumour invasiveness and tumour-host interactions
Eur J Cancer
(2006) - et al.
Altered expression of several genes in highly metastatic subpopulations of a human pulmonary adenocarcinoma cell line
Eur J Cancer
(2001) - et al.
Mononuclear cell-derived interleukin-1 beta confers chemoresistance in pancreatic cancer cells by upregulation of cyclooxygenase-2
Surgery
(2008) - et al.
Interleukin 1 receptor antagonist gene polymorphism and risk of lung cancer: a possible interaction with polymorphisms in the interleukin 1 beta gene
Lung Cancer
(2005) - et al.
Potential influence of interleukin-1 haplotype IL-1 beta-511*T-IL-1RN*1 in conferring low risk to middle third location of esophageal cancer: a case-control study
Hum Immunol
(2008) - et al.
Allele-specific induction of IL1B -31T/C promoter polymorphism by lung carcinogens
Mutat Res
(2008) - et al.
Influence of interleukin-1 beta genetic polymorphism, smoking and alcohol drinking on the risk of non-small cell lung cancer
Clin Chim Acta
(2010) - et al.
Interleukin-1beta gene polymorphisms associated with risk of lung cancer in Japanese
Lung Cancer
(2006) - et al.
Interleukin 1B gene (IL-1B) and interleukin 1 receptor antagonist gene (IL-1RN) polymorphisms in Helicobacter pylori-negative gastric cancer of intestinal and diffuse histotype
Ann Oncol
(2005)